Solventum to Participate in Upcoming Investor Conferences
SOLV(NYSE:SOLV) ST. PAUL, Minn., Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences: 2025 Wells Fargo Healthcare Conference in Boston, Mass., on Friday, Sept. 5, 2025, at 10:15 a.m. EDT. Morgan...
Solventum Announces $1.75 Billion Note Tender Offers
SOLVST. PAUL, Minn., Aug. 22, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV) announced today that it has commenced offers (each, a "Tender Offer" and, collectively, the "Tender Offers") to purchase its outstanding notes of the series listed in the table below (collectively, the...
Solventum Announces Pricing of Secondary Offering of Common Stock
SOLVST. PAUL, Minn., Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV) (the "Company" or "Solventum") today announced the pricing of the previously announced secondary offering (the "Offering") of 8,800,000 shares of its common stock, which is expected to result in gross...
Solventum Announces Launch of Secondary Offering of Common Stock
SOLVST. PAUL, Minn., Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV, "Company" or "Solventum") today announced the launch of a secondary offering (the "Offering") of 8,800,000 shares of its common stock, par value $0.01 per share, by 3M Company (the "Selling Shareholder")....
Solventum Reports Second Quarter 2025 Financial Results
SOLVReported sales increased 3.9%; organic sales increased 2.8% Increases full year organic sales growth outlook to +2.0% to +3.0% Increases full year earnings per share outlook to $5.80 to $5.95 ST. PAUL, Minn., Aug. 7, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial...
Keybanc Initiates Coverage On Solventum with Sector Weight Rating
SOLVAssessing Solventum: Insights From 9 Financial Analysts
SOLVPiper Sandler Upgrades Solventum to Overweight, Raises Price Target to $87
SOLVPiper Sandler Maintains Neutral on Solventum, Lowers Price Target to $78
SOLVSolventum Affirms FY2025 Adj EPS Guidance of $5.45-$5.65 vs $5.54 Est
SOLVSolventum Q1 Adj. EPS $1.34 Beats $1.22 Estimate, Sales $2.07B Beat $2.02B Estimate
SOLV7 Analysts Assess Solventum: What You Need To Know
SOLVPiper Sandler Maintains Neutral on Solventum, Lowers Price Target to $80
SOLVThermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
SOLVThermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth.
Solventum Enters Strategic Partnership With SprintRay
SOLVSolventum To Present Value Creation Formula And Long-Range Plan At Investor Day; Accelerate Organic Sales Growth Of 4%-5% In 2028; Expand Operating Margins To Be 23%-25% In 2028; Generate EPS CAGR Of 10% Over The 3-Year Period Ending 2028; Drive Free Cash
SOLVSolventum Reaffirms FY25 Guidance
SOLVMorgan Stanley Maintains Equal-Weight on Solventum, Raises Price Target to $80
SOLVMizuho Maintains Neutral on Solventum, Raises Price Target to $82
SOLVGoldman Sachs Maintains Sell on Solventum, Raises Price Target to $71
SOLVWhat Analysts Are Saying About Solventum Stock
SOLVWells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $75
SOLVPiper Sandler Maintains Neutral on Solventum, Raises Price Target to $84
SOLVSolventum Sees FY25 Adj. EPS $5.45-$5.65 Vs $5.50 Estimate
SOLVSolventum Q4 2024 Adj EPS $1.41 Beats $1.32 Estimate, Sales $2.07B Beat $2.05B Estimate
SOLVTrian Fund Management Which Beneficially Owns ~5% Of Solventum Corporation Comments On Solventum's Recently Announced Sale Of Its Purification & Filtration Business To Thermo Fisher Scientific
SOLVTrian Fund Management To Push Solventum To Separate More Business Units; Trian Believes Solventum Should Further Cut Costs Before Selling, Spinning Off Dental And Software Units
SOLVB of A Securities Maintains Neutral on Solventum, Raises Price Target to $85
SOLVSolventum Shares Are Up Today: What's Going On?
SOLVSolventum shares are trading higher Tuesday after the company announced it will sell its purification and filtration business to Thermo Fisher for $4.1 billion in cash.
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion
SOLVThermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.
Thermo Fisher To Acquire Solventum's Purification And Filtration Business For $4.1B In Cash
SOLVTrian Fund Management 13F Shows Added Stake In Solventum Corp From 5,360,579 To 7,126,255 Shares; Increased Stake In U-Haul Holding Co - B By 38% From 54,576 To 75,531 Shares; Increased Stake In U-Haul Holding Co By 45% From 24,056 To 34,834 Shares
SOLVSolventum Launches 3D Printed Clarity Precision Grip Attachments For Aligner Treatment, Offering Durable, Stain-Resistant Attachments That Accurately Match Digital Treatment Plans
SOLV